Univo Pharmaceuticals Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was ILS 19.322 million compared to ILS 10.141 million a year ago. Operating income was ILS 5.061 million compared to ILS 493,000 a year ago. Net income was ILS 182,000 compared to ILS 96,000 a year ago. Basic earnings per share from continuing operations was ILS 0.01.